High-Yield Pfizer Falls Off The COVID Cliff, And Survives Pfizer is a value and high-yield compared to its peers and it it outperforming expectations in 2023; The pipeline is robust. Previous Article IBM Says 7,800 Jobs (or Nearly 30% of Its Workforce) Could Be Replaced By AI Next Article MGM's Hot Hand Is All In For A Rally, After This Small Break
